Oxfendazole Development Group Report issue

Foundation Phase 2
Founded: Blue Bell PA United States (2016)

Organization Overview

First Clinical Trial
2018
NCT03435718
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Oxfendazole Development Group